Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price
on Dec 2, 2025
SONN Employees
Sonnet BioTherapeutics Holdings had 13 employees as of September 30, 2024. The number of employees increased by 1 or 8.33% compared to the previous year.
Employees
13
Change (1Y)
1
Growth (1Y)
8.33%
Revenue / Employee
$76,923
Profits / Employee
-$1,042,787
Market Cap
8.60M
Employees Chart
SONN News
- 3 days ago - Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination - GlobeNewsWire
- 17 days ago - Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting - GlobeNewsWire
- 7 weeks ago - Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma - GlobeNewsWire
- 2 months ago - Sonnet to Present at the MedInvest Biotech & Pharma Conference - GlobeNewsWire
- 4 months ago - Sonnet Releases Virtual Investor "What This Means" Segment - GlobeNewsWire
- 4 months ago - Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer - GlobeNewsWire
- 5 months ago - Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday? - Benzinga
- 5 months ago - Sonnet BioTherapeutics, Inc. Announces $888 Million Business Combination to Launch a HYPE Cryptocurrency Treasury Reserve Strategy - GlobeNewsWire